Compare Tri Chemical Laboratories Inc. with Similar Stocks
Dashboard
1
The company has declared negative results in Jan 70 after 4 consecutive negative quarters
- OPERATING CASH FLOW(Y) Lowest at JPY 1,070.57 MM
- DEBT-EQUITY RATIO (HY) Highest at -3.42 %
- INTEREST COVERAGE RATIO(Q) Lowest at 1,521.55
2
With ROE of 16.68%, it has a expensive valuation with a 2.60 Price to Book Value
3
Underperformed the market in the last 1 year
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-0.73%
0%
-0.73%
6 Months
18.16%
0%
18.16%
1 Year
27.43%
0%
27.43%
2 Years
-21.79%
0%
-21.79%
3 Years
52.91%
0%
52.91%
4 Years
44.8%
0%
44.8%
5 Years
-1.87%
0%
-1.87%
Tri Chemical Laboratories Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
20.20%
EBIT Growth (5y)
17.19%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.22
Sales to Capital Employed (avg)
0.53
Tax Ratio
25.13%
Dividend Payout Ratio
20.62%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
19.25%
ROE (avg)
16.41%
Valuation key factors
Factor
Value
P/E Ratio
16
Industry P/E
Price to Book Value
2.60
EV to EBIT
13.94
EV to EBITDA
11.00
EV to Capital Employed
2.67
EV to Sales
3.70
PEG Ratio
0.31
Dividend Yield
NA
ROCE (Latest)
19.15%
ROE (Latest)
16.68%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Mildly Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jan'26 - QoQ
Jan'26
Oct'25
Change(%)
Net Sales
5,872.80
5,635.30
4.21%
Operating Profit (PBDIT) excl Other Income
1,922.50
1,863.10
3.19%
Interest
15.50
122.40
-87.34%
Exceptional Items
0.00
0.00
Consolidate Net Profit
1,493.60
1,244.80
19.99%
Operating Profit Margin (Excl OI)
228.30%
245.60%
-1.73%
USD in Million.
Net Sales
QoQ Growth in quarter ended Jan 2026 is 4.21% vs -2.93% in Oct 2025
Consolidated Net Profit
QoQ Growth in quarter ended Jan 2026 is 19.99% vs -20.68% in Oct 2025
Annual Results Snapshot (Consolidated) - Jan'26
Jan'26
Jan'25
Change(%)
Net Sales
23,883.20
18,905.90
26.33%
Operating Profit (PBDIT) excl Other Income
7,819.70
6,628.90
17.96%
Interest
150.50
23.70
535.02%
Exceptional Items
0.00
0.00
Consolidate Net Profit
5,515.20
4,962.00
11.15%
Operating Profit Margin (Excl OI)
247.10%
278.00%
-3.09%
USD in Million.
Net Sales
YoY Growth in year ended Jan 2026 is 26.33% vs 68.11% in Jan 2025
Consolidated Net Profit
YoY Growth in year ended Jan 2026 is 11.15% vs 100.84% in Jan 2025
About Tri Chemical Laboratories Inc. 
Tri Chemical Laboratories Inc.
Diversified
No Details Available.
Company Coordinates 
No Company Details Available






